tenofovir disoproxil fumarate/lamivudine/dolutegravir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for tenofovir disoproxil fumarate/lamivudine/dolutegravir, covering 2024-08-09 to 2024-08-09. Get the full timeline:
Most recent: Clinical Trial Update: Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial [Phase 2]